echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > JAMA: Who is stronger with GLP-1 receptor agonists for weight control?

    JAMA: Who is stronger with GLP-1 receptor agonists for weight control?

    • Last Update: 2022-01-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The STEP study confirmed that weekly 2.
    4 mg of the GLP-1 receptor agonist semaglutide was effective in reducing body weight in obese people, regardless of whether they had diabetes
    .


    Semaglutide is the second GLP-1 receptor agonist approved for weight management, the first being liraglutide


    Diabetes : We investigated the difference in efficacy and adverse events between weekly subcutaneous 2.


    The mean weight change from baseline was -15.
    8% in the semaglutide group, -6.
    4% in the liraglutide group, and -1.


    Weight control effect of semaglutide vs liraglutide

    Weight Control Effects of Semaglutide vs Liraglutide Weight Control Effects of Semaglutide vs Liraglutide

    The study concluded that in obese or overweight non-diabetic patients, once-weekly semaglutide was more effective than once-daily liraglutide for weight loss
    .



    In obese or overweight non-diabetic patients, once-weekly semaglutide was superior to once-daily liraglutide for weight loss
    .
    In obese or overweight non-diabetic patients, once-weekly semaglutide was superior to once-daily liraglutide for weight loss
    .

    Original Source:
    Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes The STEP 8 Randomized Clinical Trial.
    JAMA LEAVES THIS
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.